Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain

Background:Desirable product attributes for treatment of moderate-to-severe acute pain in many medically supervised settings are rapid onset and a route of administration not requiring intravenous access. The pharmacokinetic characteristics of sublingually administered tablets containing 15 or 30 µg